Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-23T00:02:14.306Z Has data issue: false hasContentIssue false
  • English
  • Français

Transcatheter left atrial decompression in patients with dilated cardiomyopathy: bridging to cardiac transplantation or recovery

Published online by Cambridge University Press:  26 February 2019

Anna Bauer ,
Markus Khalil ,
Dorle Schmidt ,
Sabine Recla ,
Jürgen Bauer ,
Anoosh Esmaeili ,
Gemma Penford ,
Hakan Akintuerk  and
Dietmar Schranz
Anna Bauer
Affiliation:
Hessen Pediatric Heart Center, Justus Liebig University Clinic Giessen, Giessen, Germany
Markus Khalil
Affiliation:
Hessen Pediatric Heart Center, Justus Liebig University Clinic Giessen, Giessen, Germany
Dorle Schmidt
Affiliation:
Hessen Pediatric Heart Center, Justus Liebig University Clinic Giessen, Giessen, Germany
Sabine Recla
Affiliation:
Hessen Pediatric Heart Center, Justus Liebig University Clinic Giessen, Giessen, Germany
Jürgen Bauer
Affiliation:
Hessen Pediatric Heart Center, Justus Liebig University Clinic Giessen, Giessen, Germany
Anoosh Esmaeili
Affiliation:
Johann Wolfgang Goethe University Clinic Frankfurt, Frankfurt, Germany
Gemma Penford
Affiliation:
Birmingham Children’s Hospital, Steelhouse Lane, BirminghamB4 6NH, UK
Hakan Akintuerk
Affiliation:
Hessen Pediatric Heart Center, Justus Liebig University Clinic Giessen, Giessen, Germany
Dietmar Schranz*
Affiliation:
Hessen Pediatric Heart Center, Justus Liebig University Clinic Giessen, Giessen, Germany
*
Author for correspondence: Prof. Dr Dietmar Schranz, Pediatric Heart Center, Feulgenstr. 12, Justus Liebig University Clinic, 30385 Giessen, Germany. Tel: +49-171-2690294; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Left atrial congestion results from backward failure in dilated cardiomyopathy. We aimed to evaluate feasibility and efficacy of percutaneous atrioseptostomy to create a restrictive atrial septum defect in management of dilated cardiomyopathy.

Methods and results

From June 2009 to December 2016, 27 interventions comprised left atria decompressions in 22 dilated cardiomyopathy patients; 9 females; age: 24 days to 36.9 years; weight: 3–50 kg; NYHA-/Ross class IV (n=16). Mean left ventricular ejection fraction was 21.5±9.7% and brain natriuretic peptide was 2291±1992 pg/ml. Dilated cardiomyopathy was classified as chronic (n=9); acute (n=1) myocarditis; idiopathic (n=5); left ventricular non-compaction (n=4); mitochondriopathy, pacemaker induced, and arrhythmogenic (n=3). Atrioseptostomy was concomitantly performed with myocardial biopsies 6.5 days (±11.7) after admission (n=11). Trans-septal puncture was used in 18 patients; foramen ovale dilatation was done in four patients. Mean balloon size was 11 mm (range 7–14 mm); total procedure time was 133±38 minutes. No procedural complications were observed. Mean left atrial pressure decreased from 15.8±6.8 to 12.2±4.8 mmHg (p=0.005), left/right atrial pressure gradient from 9.6±5.6 to 5±3.5 mmHg; brain natriuretic peptide (n=18) decreased from 1968±1606 to 830±1083 pg/ml (p=0.01). One patient unsuitable for heart transplantation died at home despite additionally performed pulmonary artery banding and three further left atrial decompressions; five patients were bridged to transplantation, two died afterwards. Functional recovery occurred in the remaining 14 patients and in six after additional pulmonary artery banding. No patient required assist device.

Conclusions

Percutaneous left atrial decompression is an age-independent, effective palliation treating patients with dilated cardiomyopathy.

Keywords

Atrioseptostomyleft atrial congestiondilative cardiomyopathyrestrictive atrial septum defect
Type
Original Article
Information
Cardiology in the Young , Volume 29 , Issue 3 , March 2019 , pp. 355 - 362
Copyright
© Cambridge University Press 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Cite this article: Bauer A, Khalil M, Schmidt D, Recla S, Bauer J, Esmaili A, Penford G, Akintuerk H, Schranz D. (2019) Transcatheter left atrial decompression in patients with dilated cardiomyopathy: bridging to cardiac transplantation or recovery. Cardiology in the Young29: 355–362. doi: 10.1017/S1047951118002433

References

1. Richardson, P, McKenna, W, Bristow, M, et al. Report of the 1995 World Health organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841–842.Google Scholar
2. Towbin, JA, Lowe, AM, Colan, SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. J Am Med Assoc 2006; 296: 1867–1876.Google Scholar
3. Towbin, JA, Bowles, NE. The failing heart. Nature 2002; 415: 227–233.Google Scholar
4. Everitt, MD, Sleeper, LA, Lu, M, et al. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol 2014; 63: 1405–1413.Google Scholar
5. Richartz, BM, Werner, GS, Ferrari, M, Figulla, HR. Comparison of left ventricular systolic and diastolic function in patients with idiopathic dilated cardiomyopathy and mild heart failure versus those with severe heart failure. Am J Cardiol 2002; 90: 390–394.Google Scholar
6. Tsirka, AE, Trinkaus, K, Chen, SC, et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol 2004; 44: 391–397.Google Scholar
7. Kantor, PF, Abraham, JR, Dipchand, AI, Benson, LN, Redington, AN. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy. J Am Coll Cardiol 2010; 55: 1377–1384.Google Scholar
8. Schranz, B, Akintuerk, H, Voelkel, NF. ‘End-stage’ heart failure therapy: potential lessons learnt from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation. Heart 2017; 15: 262–267.Google Scholar
9. Alexander, PMA, Daubeney, PEF, Nugent, AW, et al. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood results from a national population-based study of childhood cardiomyopathy. Circulation 2013; 29: 2039–2046.Google Scholar
10. Jordan, LC, Ichord, RN, Reinhartz, O, et al. Neurological complications and outcomes in the Berlin Heart EXCOR® pediatric investigational device exemption trial. J Am Heart Assoc 2015; 4: e001429.Google Scholar
11. Amir, G, Ma, X, Reddy, VM, et al. Dynamics of human myocardial progenitor cell populations in the neonatal period. Ann Thorac Surg 2008; 86: 1311–1319.Google Scholar
12. Mollova, M, Bersell, K, Walsh, S, et al. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci USA 2013; 110: 1446–1451.Google Scholar
13. Schranz, D, Rupp, S, Müller, M, et al. Pulmonary artery banding in infants and young children with left ventricular dilated cardiomyopathy: a novel therapeutic strategy before heart transplantation. J Heart Lung Transplant 2013; 32: 475–481.Google Scholar
14. Feldman, T, Komtebedde, J, Burkhoff, D, et al. Transcatheter interatrial shunt device for the treatment of heart failure: rationale and design of the randomized trial to REDUCE elevated left atrial pressure in heart failure (REDUCE LAP-HF I). Circ Heart Fail 2016; 9: pii: e003025.Google Scholar
15. Burkhoff, D, Maurer, MS, Joseph, SM, et al. Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations. JACC Heart Fail 2015; 3: 275–282.Google Scholar
16. Johnston, TA, Jaggers, J, McGovern, JJ, O’Laughlin, MP. Bedside transseptal balloon dilation atrial septostomy for decompression of the left heart during extracorporeal membrane oxygenation. Catheter Cardiovasc Interv 1999; 46: 197–199.Google Scholar
17. Kotani, Y, Chetan, D, Rodrigues, W, et al. Left atrial decompression during veno-arterial extracorporeal membrane oxygenation for left ventricular failure in children: current strategy and clinical outcomes. Artif Organs 2013; 37: 29–36.Google Scholar
18. Lin, YN, Chen, YH, Wang, HJ, Hung, JS, Chang, KC, Lo, PH. Atrial septostomy for left atrial decompression during extracorporeal membrane oxygenation by Inoue balloon catheter. Circ J. 2017; 81: 1419–1423.Google Scholar
19. Schranz, D, Bauer, A, Reich, B, et al. Fifteen-year single center experience with the “Giessen Hybrid” approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol. 2015; 36: 365–373.Google Scholar
20. Rupp, S, Michel-Behnke, I, Valeske, K, Akintürk, H, Schranz, D. Implantation of stents to ensure an adequate interatrial communication in patients with hypoplastic left heart syndrome. Cardiol Young. 2007; 17: 535–540.Google Scholar
21. Yerebakan, C, Murray, J, Valeske, K, et al. Long-term results of biventricular repair after initial Giessen Hybrid approach for hypoplastic left heart variants. J Thorac Cardiovasc Surg 2015; 149: 1112–1120.Google Scholar
22. Pinamonti, B, Di Lenarda, A, Sinagra, G, Camerini, F. Restrictive ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlation and prognostic implication. J Am Coll Cardiol 1993; 22: 808–815.Google Scholar
23. Kaye, D, Shah, SJ, Borlaug, BA, et al. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure. J Card Fail 2014; 20: 212–221.Google Scholar
24. Schranz, D, Akintuerk, H, Bailey, L. Pulmonary artery banding for functional regeneration of end-stage dilated cardiomyopathy in young children: world network report. Circulation 2018; 137: 1410–1412.Google Scholar
25. Ellison, DH, Felker, GM. Diuretic treatment in heart failure. N Engl J Med 2017; 377: 1964–1975.Google Scholar
26. Schranz, D. Diuretic treatment in heart failure. N Engl J Med 2018; 378 (7): 683.Google Scholar
27. Rossignol, P, Zannad, F. Left-to-right atrial shunting: new hope for heart failure? Lancet 2016; 387: 1253–1255.Google Scholar